Nonlinear Dynamics and PerkinElmer to Supply Progenesis SameSpots Software with Geliance 1000 Imager
Complete the form below to unlock access to ALL audio articles.
Nonlinear Dynamics Ltd has announced that PerkinElmer, Inc. will supply Progenesis SameSpots with the Geliance 1000 Imaging System, which was launched at the recent HUPO 6th Annual Congress.
Both companies showcased their complimentary technologies at an event where interest in 2D gel image analysis and proteomics was high. This trend reflects the double-digit sales growth reported in Asia/Pacific by proteomics tool suppliers and market predictions made at the end of 2006. In addition Nonlinear’s own data shows increasing numbers of publications from the Far East that reference 2D gel electrophoresis.
Progenesis SameSpots and the Geliance 1000 support this interest by offering significant increases in speed. The time needed to run enough samples for findings from biological populations has been a major limitation for proteomics; SameSpots offers a solution to this problem using 2D gels. The benefits of the SameSpots workflow were highlighted in a recent press release from Nonlinear Dynamics. This described research by the National Cancer Research Institute in Japan where biomarkers were validated on a clinical scale within 12 months of installing Progenesis SameSpots.
The increase in analysis speed available with Progenesis SameSpots compliments the performance of the new Geliance 1000 which is able to acquire an image up to five times faster than standard scanning systems, according to company.
Will Dracup, CEO of Nonlinear Dynamics said, “The HUPO 6th annual congress in Korea was one of the busiest events for Nonlinear that I have ever been to. We were there alongside our partners, including PerkinElmer, who are helping to take SameSpots into Asia/Pacific against a back-drop of strong interest in 2D gel analysis. Together we have addressed a key challenge in proteomics, the ability to run enough samples for reliable conclusions, with a 2D-based solution. Proteomics now has the potential to achieve even more using this key technique.”
